Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

X-PLO2R

K-Number: K203086 · 2021-03-02

Decision Date2021-03-02
Product CodeCAW
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

X-PLO2R is the device name listed in this FDA 510(k) record. The listed applicant is Belluscura, LLC. It received FDA 510(k) clearance on 2021-03-02 under 510(k) number K203086. The device is classified under product code CAW. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the X-PLO2R?

X-PLO2R is a medical device that received FDA 510(k) clearance on 2021-03-02. The listed applicant is Belluscura, LLC. The 510(k) number is K203086.

When did X-PLO2R receive FDA 510(k) clearance?

X-PLO2R received FDA 510(k) clearance on 2021-03-02, under 510(k) number K203086.

Who is the listed applicant for X-PLO2R?

The FDA 510(k) record lists Belluscura, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for X-PLO2R?

The FDA product code for X-PLO2R is CAW.

Related Devices (Code: CAW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.